StockWatch
·
HomeLiveWeekly
Biotechnology: Pharmaceutical Preparations
OtherJun 1, 2026, 06:31 AM

Dr. Reddy's Laboratories Files SEC Form 6-K

AI Summary

Dr. Reddy's Laboratories Limited has filed a Form 6-K with the SEC on May, 2026. The filing includes an exhibit related to an intimation dated May 30, 2026. The report is submitted under the Securities Exchange Act of 1934.

View SEC Filing
RDY
Biotechnology: Pharmaceutical Preparations
DR REDDYS LABORATORIES LTD

Price Impact

More from RDY

Other3h ago

Dr. Reddy's Files 6-K Submitting June 10, 2026 Intimation

ESOPJun 5, 12:06 PM

Dr. Reddy's Allots 12,100 Equity Shares Under ESOP Schemes

Corporate GovernanceMay 28, 1:21 PM

Dr. Reddy's Files Annual Secretarial Compliance Report for FY26

More in Other

COEP1d ago, 6:06 PM

Z Squared Inc. Files S-1 for Resale of 41.6M Shares

NCLA1d ago, 5:26 PM

Nuclea Energy Files for IPO, Plans NYSE Listing

EIC1d ago, 5:06 PM

Eagle Point Income Co. Estimates May NAV Per Share Between $12.52-$12.62